Hydrochloric Acid

Hydrochloric Acid

SCHEMBL83661

Cl.NNc1ccc(C(=O)O)cc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 4/20 0.48
DRD1 known ✓ P21728 1/20 0.48
PTGS2 known ✓ P35354 1/20 0.46
TSHR P16473 3/20 0.57
TP53 P04637 1/20 0.57
SRD5A2 P31213 1/20 0.50
ALDH1A1 P00352 3/20 0.48
CA1 P00915 4/20 0.48
CA12 O43570 3/20 0.48
CA9 Q16790 3/20 0.48
CA3 P07451 2/20 0.48
CA6 P23280 2/20 0.48
CA5A P35218 2/20 0.48
CA7 P43166 2/20 0.48
CA14 Q9ULX7 2/20 0.48
CA5B Q9Y2D0 2/20 0.48
TYR P14679 1/20 0.48
CA4 P22748 1/20 0.48
MAPT P10636 2/20 0.47
TDP1 Q9NUW8 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrazine SCHEMBL28169554 0.98 TSHR (0.55) TSHRTP53SRD5A2ALDH1A1CA1
SCHEMBL7034 0.98 TSHR (0.60) TSHRTP53SRD5A2ALDH1A1CA1
Hydrazine SCHEMBL28420061 0.95 TSHR (0.57) TSHRTP53SRD5A2ALDH1A1CA1
Charcoal, Activated SCHEMBL31491472 0.95 TSHR (0.57) TSHRTP53SRD5A2ALDH1A1CA1
Bromide SCHEMBL20984518 0.95 TSHR (0.57) TSHRTP53SRD5A2ALDH1A1CA1
Phenylhydrazine SCHEMBL28137921 0.94 LMNA (0.58) TSHRTP53SRD5A2ALDH1A1MAPT
Oxalic Acid SCHEMBL20984984 0.93 TSHR (0.55) TSHRTP53SRD5A2ALDH1A1CA1
Hydrochloric Acid SCHEMBL15688237 0.93 TSHR (0.55) TSHRTP53SRD5A2ALDH1A1CA1
Formaldehyde SCHEMBL27512000 0.93 TSHR (0.55) TSHRTP53SRD5A2ALDH1A1CA1
Phenylhydrazine SCHEMBL20984743 0.89 LMNA (0.58) TSHRTP53SRD5A2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025081381-A1 NANOPARTICLES CAPABLE OF REALIZING CONTROLLED RELEASE OF CARBON MONOXIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院深圳先进技术研究院 2025-04-24 WO claimed
CN-115650960-B Carboxylesterase 1 specific near infrared fluorescent probe for pesticide residue detection and application thereof 大连理工大学 2024-06-11 CN claimed
CN-117414347-A Nanoparticle capable of controllably releasing carbon monoxide and preparation method and application thereof 中国科学院深圳先进技术研究院 2024-01-19 CN claimed
CN-114075146-A Preparation method of deferasirox impurity 江苏奥赛康药业有限公司 2022-02-22 CN claimed
US-11040938-B2 Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2021-06-22 US claimed
CN-109776563-B Vomitoxin hapten, preparation method thereof, artificial antigen, kit and vomitoxin detection method 国家食品安全风险评估中心 2020-06-30 CN claimed
CN-107663161-B Continuous flow synthesis process of phenylhydrazine salt and substituted phenylhydrazine salt 上海惠和化德生物科技有限公司 2020-04-10 CN claimed
US-20190152896-A1 Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) 2019-05-23 US claimed
CN-109438294-A The denitrogenation arylation method and product and application of sulfimide or sulfonamide 怀化学院 2019-03-08 CN claimed
CN-106674078-B A kind of near-infrared ratio that is used to prepare shines the compound of up-conversion nano material, preparation method and application 郑州大学 2019-03-08 CN claimed
CN-108623511-A A kind of indole amides class compound can be used for treating cancer 南华大学 2018-10-09 CN claimed
CN-106749288-B N- (substituted-phenyl) Bi Zuo Bing fraxinellones analog derivative, preparation method and application 郑州大学 2018-07-10 CN claimed
CN-107814748-A A kind of preparation method of 4 hydrazinobenzoic acid hydrochloride 天津市化学试剂研究所有限公司 2018-03-20 CN claimed
CN-105733564-B A kind of Ratiometric fluorescent probe sensitive Mitochondrially targeted pH and its preparation method and application 郑州大学 2018-01-05 CN claimed
CN-106749288-A N (substituted benzene) base Bi Zuo Ji fraxinellones analog derivative, its preparation method and application 郑州大学 2017-05-31 CN claimed
CN-106674078-A Compound for preparing near-infrared rate light-emitting upconversion nanomaterial as well as preparation method and application of compound 郑州大学 2017-05-17 CN claimed
CN-106565697-A Lysosome positioning fluorescence probe, preparation method, and application in arginine detection in near infrared ratio 郑州大学 2017-04-19 CN claimed
CN-105733564-A Mitochondrially-targeted pH-sensitive ratio-type fluorescent probe and preparation method and application thereof 郑州大学 2016-07-06 CN claimed
CN-105019013-A Blue-light emitting monocrystalline material preparation method UNIV TAIYUAN TECHNOLOGY 2015-11-04 CN claimed
EP-0384769-B1 Protein labelling JOHNSON MATTHEY PLC (GB) 1996-04-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11040938-B2 Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts HPD, TYR, PDK2 CA2 931/4885DRD1 414/4885PTGS2 2185/4885
US-20190152896-A1 Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts HPD, TYR, PDK2 CA2 931/4885DRD1 414/4885PTGS2 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.